BARINTHUS BIOTHERAPEUTICS PLC Deferred Foreign Income Tax Expense (Benefit)
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Deferred Foreign Income Tax Expense (Benefit) of -$4.34 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-24.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2023-03-24
- BARINTHUS BIOTHERAPEUTICS PLC deferred foreign income tax expense (benefit) for fiscal 2022 was -$4.34M.
- BARINTHUS BIOTHERAPEUTICS PLC deferred foreign income tax expense (benefit) for fiscal 2021 was -$119.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2022-12-31 | -$4.34M 10-K · filed 2023-03-24 |
| 2021-12-31 | -$119.00K 10-K · filed 2023-03-24 |